Tvardi Therapeutics Inc. (TVRD) has disclosed a new risk, in the Regulation category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tvardi Therapeutics Inc. faces the risk that stricter enforcement or expansion of animal welfare regulations such as the AWA could materially increase research and compliance costs. Noncompliance by the company or its third-party contractors could result in fines, operational disruption, and reputational damage, ultimately hindering product development and commercialization efforts.
The average TVRD stock price target is $6.25, implying 108.33% upside potential.
To learn more about Tvardi Therapeutics Inc.’s risk factors, click here.